JP2025517965A5 - - Google Patents

Info

Publication number
JP2025517965A5
JP2025517965A5 JP2024569102A JP2024569102A JP2025517965A5 JP 2025517965 A5 JP2025517965 A5 JP 2025517965A5 JP 2024569102 A JP2024569102 A JP 2024569102A JP 2024569102 A JP2024569102 A JP 2024569102A JP 2025517965 A5 JP2025517965 A5 JP 2025517965A5
Authority
JP
Japan
Prior art keywords
rnai construct
construct according
nucleotide
approximately
modified nucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024569102A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025517965A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/067384 external-priority patent/WO2023230495A2/en
Publication of JP2025517965A publication Critical patent/JP2025517965A/ja
Publication of JP2025517965A5 publication Critical patent/JP2025517965A5/ja
Pending legal-status Critical Current

Links

JP2024569102A 2022-05-25 2023-05-24 Ｓｃａｐ発現を阻害するためのｒｎａｉコンストラクト及びその使用方法 Pending JP2025517965A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263345513P 2022-05-25 2022-05-25
US63/345,513 2022-05-25
PCT/US2023/067384 WO2023230495A2 (en) 2022-05-25 2023-05-24 Rnai constructs for inhibiting scap expression and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2025517965A JP2025517965A (ja) 2025-06-12
JP2025517965A5 true JP2025517965A5 (enExample) 2026-05-20

Family

ID=88920082

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024569102A Pending JP2025517965A (ja) 2022-05-25 2023-05-24 Ｓｃａｐ発現を阻害するためのｒｎａｉコンストラクト及びその使用方法

Country Status (14)

Country Link
US (1) US20250313834A1 (enExample)
EP (1) EP4531871A2 (enExample)
JP (1) JP2025517965A (enExample)
KR (1) KR20250017218A (enExample)
CN (1) CN119300841A (enExample)
AR (1) AR129463A1 (enExample)
AU (1) AU2023277621A1 (enExample)
CA (1) CA3257118A1 (enExample)
CL (1) CL2024003564A1 (enExample)
IL (1) IL316643A (enExample)
MX (1) MX2024014428A (enExample)
TW (1) TW202413642A (enExample)
UY (1) UY40288A (enExample)
WO (1) WO2023230495A2 (enExample)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2120580B1 (en) * 2007-02-02 2017-12-27 Baylor College Of Medicine Compositions and methods for the treatment of metabolic disorders
SG11202113112WA (en) * 2019-05-30 2021-12-30 Amgen Inc Rnai constructs for inhibiting scap expression and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2023537943A5 (enExample)
TWI823866B (zh) 用於抑制類血管生成素蛋白-3(ANGPTL3)表現的RNAi藥劑及組合物及使用方法
TWI880645B (zh) 抑制lpa之基因表現之組合物及方法
JP2023103244A5 (enExample)
US12303525B2 (en) Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection
JP2022511550A5 (enExample)
JP6060178B2 (ja) 高効率のナノ粒子型二本鎖オリゴｒｎａ構造体およびその製造方法
CN103333890B (zh) 治疗乙型病毒性肝炎的rna干扰制剂
JP2026077722A (ja) Ｄｕｘ４阻害剤およびその使用方法
JP2024105284A5 (enExample)
JP2009513144A5 (enExample)
JP2010532163A5 (enExample)
CA3112716A1 (en) Organic compositions to treat hsf1-related diseases
JP2022534402A5 (enExample)
JP2024538859A5 (enExample)
CN117264949A (zh) 抑制Apo(a)基因表达的siRNA及其组合物
JP2023506546A (ja) Ｂ型肝炎ウイルス感染症を処置するためのｓｅｐｔ９阻害剤の使用
EP3587577A1 (en) Asymmetric sirna for inhibiting expression of male pattern hair loss target gene
JP2023538630A (ja) Ｂ型肝炎ウイルス感染症を処置するためのａ１ｃｆ阻害剤の使用
JP2023506540A (ja) Ｂ型肝炎ウイルス感染を処置するためのｓｃａｍｐ３阻害剤の使用
JP2025512771A5 (enExample)
KR20260040626A (ko) 안지오텐시노겐을 표적으로 하는 올리고뉴클레오티드 및 이의 용도
JP2023506954A (ja) Ｂ型肝炎ウイルス感染を処置するためのｓａｒａｆ阻害剤の使用
JP2024539097A5 (enExample)
WO2023168202A2 (en) Certain dux4 inhibitors and methods of use thereof